Although it is an important technology for studying genomes, DNA sequencing was initially accomplished in 1977 by Frederick Sanger. Since its conception, the technology has developed rapidly. Alvaro G ...

After rolling out not one but two major DNA sequencing machine launches this past year, Pacific Biosciences has put forward massive gains in its quarterly and annual revenues. In a preliminary look at ...

Illumina exhibits better profitability ratios than many of its peers, which indicates that the company could continue to invest in its operations. In Q3 2025, ILMN raised its EPS to $4.65-$4.75, ...

Pacific Biosciences’ stock price dropped more than 40% this morning after disclosing that revenues from its new DNA sequencing machines are expected to fall below expectations, and that the company ...

Two competing companies will soon offer machines capable of sequencing a human genome in 24 hours, rather than weeks or months. On Tuesday (January 10), Illumina Inc. and Life Technologies Corp. both ...

With Illumina's divestiture of GRAIL, the company will improve its operating expenses, since GRAIL reported significant losses while it was part of Illumina. The global DNA sequencing market is ...